Anupam Dalal
CIK: 0001602474
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Whitehawk Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 12, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
38K shares- - May 14, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)Indirect1.3M shares at avg. $3.92$5.0M - Jun 12, 2025WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
40K shares- - Mar 4, 2025AADI
Aadi Bioscience, Inc.
Award(A)Indirect1.6M shares at avg. $2.40$3.7M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 38,040 | - | - | Direct |
| May 14, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) | 1,275,510 | $3.92 | $4,999,999 | Indirect |
| Jun 12, 2025 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 40,006 | - | - | Direct |
| Mar 4, 2025 |  AADI Aadi Bioscience, Inc. | Award(A) | 1,561,000 | $2.40 | $3,746,400 | Indirect |
1-4 of 4 transactions
About Dalal Anupam
Dalal Anupam (SEC CIK 0001602474) files insider reports with the SEC as Director of Whitehawk Therapeutics, Inc. (WHWK).
Signal8 holds 3 ownership filings by Dalal Anupam, all Form 4s, filed between Mar 5, 2025 and Jul 30, 2026. Those filings report 4 transactions, from Mar 4, 2025 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dalal Anupam's filings is in MORRISTOWN, NJ.
Recent filings by Dalal Anupam
Other insiders filing for Whitehawk Therapeutics, Inc. (WHWK)
- Giacobello Scott M., CHIEF FINANCIAL OFFICER
- BALL BRYAN
- Dornan David, Chief Scientific Officer
- Lennon David James, CHIEF EXECUTIVE OFFICER
- Dugan Margaret, Chief Medical Officer
- Iyengar Vijay K, Director